The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
125295021 12529502 1 I 20111108 20160706 20160706 EXP DE-CIPLA LTD.-2011DE00212 CIPLA SCHUETTE W, NAGEL S, WEIKERSTHAL LFV, PABST S, SCHUMANN C, DEUSS B ET AL.,. RANDOMIZED PHASE III TRIAL OF DOCETAXEL PLUS CARBOPLATIN WITH OR WITHOUT LEVOFLOXACIN PROPHYLAXIS IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER THE APRONTA TRIAL. JOURNAL OF THORACIC ONCOLOGY. 2011;6 (12):2090 TO 2096 0.00 Y 0.00000 20160706 OT DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
125295021 12529502 1 PS CARBOPLATIN. CARBOPLATIN 1 Intravenous (not otherwise specified) AREA UNDER THE CURVE 6, DAY 1, EVERY 3 WEEKS U U 77383
125295021 12529502 2 SS DOCETAXEL. DOCETAXEL 1 Intravenous (not otherwise specified) 75 MG/M2, DAY 1, EVERY 3 WEEKS U U 0 75 MG/M**2
125295021 12529502 3 SS PLACEBO UNSPECIFIED INGREDIENT 1 Oral QD, ON DAYS 5 TO 11, EVEY 3 WEEKS U U 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
125295021 12529502 1 Non-small cell lung cancer
125295021 12529502 2 Non-small cell lung cancer

Outcome of event

Event ID CASEID OUTC COD
125295021 12529502 OT
125295021 12529502 DE

Reactions reported

Event ID CASEID DRUG REC ACT PT
125295021 12529502 Neutropenia
125295021 12529502 Pyrexia
125295021 12529502 Sepsis

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

no results found